weekly RRMS and 'early therapy' in patients with an initial demyelinating event and high risk of occurrence of clinically definite MS Rebif ... dose limit Secondary progressive, progressive ...

They help change relapsing-remitting MS (RRMS) and secondary progressive MS (SPMS ... of certain immune system cells and chemicals. Cladribine (Mavenclad) is a pill that you take for a total ...

There isn’t enough evidence to back the use of Novartis Mayzent for secondary progressive multiple sclerosis on the ... KGaA’s oral therapy Mavenclad (cladribine), which was approved for ...

Cladribine, a synthetic deoxyadenosine analog, is an oral immunomodulatory agent that produces targeted, sustained reduction of T and B lymphocytes. This mechanism of action provides the rationale ...